RCT of the Naturopathic Anti-Inflammatory Diet
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00334919 |
Recruitment Status :
Completed
First Posted : June 8, 2006
Last Update Posted : June 24, 2010
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Diabetes Mellitus, Type 2 Prediabetes | Behavioral: Diet (Anti-Inflammatory or standard diabetic diet) | Phase 2 |
This study will test the effects of two different diets on the immune system and inflammation in diabetes and pre-diabetes. These diets are the "Anti-Inflammatory Diet" (AI Diet) used by many naturopathic doctors and a standard diabetic diet based on the American Diabetes Association recommendations (ADA Diet). The AI diet excludes wheat, dairy products, eggs, red meat, caffeine, alcohol, peanuts and certain fruits and vegetables. The ADA diet includes most foods but controls the amount of each of the food groups.
Naturopathic physicians often use healthful diets to treat diseases but many of these diets have not been compared to usual medical diet treatments. We will be looking at blood markers that show how the immune system responds to the different diets. We are expecting that the AI diet will result in less inflammation and a better response by the immune system than the ADA diet. We will also be looking at levels of blood lipids and glucose to see any effects on these risk factors.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 30 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Randomized Clinical Trial of the Naturopathic Anti-Inflammatory Diet |
Study Start Date : | May 2006 |
Actual Primary Completion Date : | December 2007 |
Actual Study Completion Date : | December 2007 |
- Behavioral: Diet (Anti-Inflammatory or standard diabetic diet)
6 weeks standard ADA diet, then randomized to either ADA or antiinflammatory (AI) diet for 6 weeks
- Cytokines [ Time Frame: 13 weeks ]
- Glucose [ Time Frame: 113 weeks ]
- Weight [ Time Frame: 13 weeks ]
- Lipids [ Time Frame: 13 weeks ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- BMI: 25-45 kg/m2
- Age 18-75 yrs
- Diagnosed with type 2 diabetes or pre-diabetes
- At risk for type 2 diabetes. Must meet 2 of the following 3 criteria: BMI 30-45 kg/m2, age 50 or older, and/or family history of type 2 diabetes
- Fasting blood glucose of 100-200 mg/dl
- Provide informed consent
Exclusion Criteria:
- Current major debilitating mental or physical illness that would interfere with participation (as determined by the participant's medical history)
- Taking diabetic medication other than sulfonylurea
- Taking Gymnema silvestra (a naturopathic diabetes treatment)
- Taking medications that have anti-inflammatory affects (lipid lowering agents, NSAIDS, COX 2 inhibitors, aspirin, HRT, oral contraceptives, testosterone, seizure medications)
- Taking weight loss medications
- Severe renal, hepatic, or heart disease
- Triglycerides >500 mg/dL
- Bulimia
- Pregnancy or lactation
- Current excessive use of alcohol
- Current/recent chronic use of recreational drugs
- Smoker
- More than 4 hours/week of aerobic exercise
- Have gained or lost more than 15 pounds during previous 6 months
- Planning on moving out of the area in the next 4 months
- Is a participant in another medical research study
- Is following a weight loss diet
- Is unwilling to accept random assignment of the experimental diets
- Food preferences and/or allergies that will interfere with consumption of experimental diet

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00334919
United States, Oregon | |
Oregon Health & Science University General Clinical Research Center | |
Portland, Oregon, United States, 97239 |
Principal Investigator: | Patricia Elmer, PhD | National College of Naturopathic Medicine |
Responsible Party: | Patricia Elmer, PhD, Helfgott Research Institute |
ClinicalTrials.gov Identifier: | NCT00334919 |
Other Study ID Numbers: |
R21AT002374-01A1 ( U.S. NIH Grant/Contract ) R21AT002374-01A1 ( U.S. NIH Grant/Contract ) |
First Posted: | June 8, 2006 Key Record Dates |
Last Update Posted: | June 24, 2010 |
Last Verified: | May 2009 |
Diabetes Pre-Diabetes Anti-Inflammatory Diet |
Diet Study Inflammation Diabetic Diet |
Diabetes Mellitus, Type 2 Diabetes Mellitus Glucose Metabolism Disorders |
Metabolic Diseases Endocrine System Diseases Anti-Inflammatory Agents |